XTLB
Price:
$1.88
Market Cap:
$20.04M
XTL Biopharmaceuticals Ltd., a biopharmaceutical company, engages in the acquisition and development of pharmaceutical products for the treatment of autoimmune diseases. The company's lead drug candidate is hCDR1, a Phase II-ready asset for the treatment of systemic lupus erythematosus and Sjogren's syndrome. It has a licensing agreement with Yeda Research and Development Company Limited for the research, development, and commercialization of hCDR1 for various indications. The company was formerly known as Xenograft Technologies Ltd. and changed its name to XTL Biopharmaceuticals Ltd. in July 1995. XTL Biopharmaceuticals Ltd. was incorporated in 1993 and is headquartered in Ramat Gan, Israel...[Read more]
Industry
Biotechnology
IPO Date
2005-09-01
Stock Exchange
NASDAQ
Ticker
XTLB
According to XTL Biopharmaceuticals Ltd.’s latest financial reports and current stock price. The company's current Current Ratio is 11.43. This represents a change of -10.02% compared to the average of 12.70 of the last 4 quarters.
The mean historical Current Ratio of XTL Biopharmaceuticals Ltd. over the last ten years is 18.53. The current 11.43 Current Ratio has changed 6.07% with respect to the historical average. Over the past ten years (40 quarters), XTLB's Current Ratio was at its highest in in the September 2016 quarter at 12.70K. The Current Ratio was at its lowest in in the March 2015 quarter at 0.
Average
18.53
Median
20.52
Minimum
3.24
Maximum
32.39
Discovering the peaks and valleys of XTL Biopharmaceuticals Ltd. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 202.36%
Maximum Annual Current Ratio = 32.39
Minimum Annual Increase = -51.20%
Minimum Annual Current Ratio = 3.24
Year | Current Ratio | Change |
---|---|---|
2023 | 9.93 | -51.20% |
2022 | 20.35 | -24.62% |
2021 | 27.00 | 12.04% |
2020 | 24.10 | -18.14% |
2019 | 29.44 | -9.11% |
2018 | 32.39 | 56.58% |
2017 | 20.69 | 147.88% |
2016 | 8.35 | -14.69% |
2015 | 9.78 | 202.36% |
2014 | 3.24 | -22.50% |
The current Current Ratio of XTL Biopharmaceuticals Ltd. (XTLB) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
19.09
5-year avg
22.16
10-year avg
18.53
XTL Biopharmaceuticals Ltd.’s Current Ratio is less than Benitec Biopharma Inc. (15.01), greater than Xenetic Biosciences, Inc. (6.96), greater than ProPhase Labs, Inc. (1.47), greater than BiondVax Pharmaceuticals Ltd. (6.15), greater than B.O.S. Better Online Solutions Ltd. (2.49),
Company | Current Ratio | Market cap |
---|---|---|
15.01 | $268.85M | |
6.96 | $6.40M | |
1.47 | $15.04M | |
6.15 | $4.97M | |
2.49 | $18.90M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like XTL Biopharmaceuticals Ltd. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like XTL Biopharmaceuticals Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Current Ratio?
How can you use the Current Ratio?
What is XTL Biopharmaceuticals Ltd.'s Current Ratio?
How is the Current Ratio calculated for XTL Biopharmaceuticals Ltd. (XTLB)?
What is the highest Current Ratio for XTL Biopharmaceuticals Ltd. (XTLB)?
What is the 3-year average Current Ratio for XTL Biopharmaceuticals Ltd. (XTLB)?
What is the 5-year average Current Ratio for XTL Biopharmaceuticals Ltd. (XTLB)?
How does the current Current Ratio for XTL Biopharmaceuticals Ltd. (XTLB) compare to its historical average?